Fundraising FoxCotherabio
San Mateo, US · 1 known investors
Find your way into Cotherabio
Sign up to see every warm intro you have to Cotherabio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cotherabio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.
Investors · 1
Frequently asked questions
- What does Cotherabio do?
- Cothera Bioscience is a clinical-stage biopharmaceutical company developing small molecule therapies targeting previously undruggable oncology targets through synthetic lethality, protein degradation, and immunotherapy mechanisms. The company's lead candidates are in Phase 2 trials for hematologic malignancies and high-grade gliomas with specific genetic mutations.
- Who are Cotherabio's investors?
- Cotherabio's investors include Pan-Lin Capital.
- Where is Cotherabio headquartered?
- Cotherabio is headquartered in San Mateo, US.